Dear Colleagues,

Over the past decade, exponential advances in molecular and cellular therapies have boosted the understanding of applying innovative diagnostic and therapeutic tools for identifying and treating cardiovascular disease. It is hoped that these attempts will provide efficient curative approaches for various cardiovascular health problems. Delineating the underlying mechanisms and molecular players in various heart diseases represents an essential basis for successful cardiac regenerative medicine. In this issue entitled Molecular and Cellular Therapeutics of Cardiovascular Diseases, authors are warmly invited to submit original and review papers which present recent advances in the rapidly changing field of cardiovascular diseases. This Special Issue will be a collection of the present research on cardiovascular disease, ranging from molecular aspects to new therapies. For this reason, we are pleased to encourage all colleagues working in this field to contribute.

Prof. Eltyeb Abdelwahid and Prof. Katherine Athayde Teixeira de Carvalho
Guest Editors

Manuscripts should be submitted via our online editorial system at https://www.biolifesas.org/journalx_brha/authorLogOn.action by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. Submitted manuscripts should be well formatted in good English.